• 12 Hits
  • 検索条件 : 絞込み (MeSH = Colon / drug effects)
生物種 リソース名 タイトル
ヒト・動物細胞 ACL-15(RCB0510) Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+.
ヒト・動物細胞 RAW 264(RCB0535) Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
ヒト・動物細胞 CACO-2(RCB0988) , CHO Toxicity studies of coumarin 6-encapsulated polystyrene nanospheres conjugated with peanut agglutinin and poly(N-vinylacetamide) as a colonoscopic imaging agent in rats.
ヒト・動物細胞 CACO-2(RCB0988) Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy.
ヒト・動物細胞 RAW 264(RCB0535) CPT-11-Induced Delayed Diarrhea Develops via Reduced Aquaporin-3 Expression in the Colon.
一般微生物 JCM 17581 , JCM 14654 Relationship of Enhanced Butyrate Production by Colonic Butyrate-Producing Bacteria to Immunomodulatory Effects in Normal Mice Fed an Insoluble Fraction of Brassica rapa L.
ヒト・動物細胞 CACO-2(RCB0988) Lignosulfonic Acid-Induced Inhibition of Intestinal Glucose Absorption.
ヒト・動物細胞 CACO-2(RCB0988) , CW-2(RCB0778) Suppressive action of acetate on interleukin-8 production via tubulin-α acetylation.
ヒト・動物細胞 Neonatal inoculation with the protein-bound polysaccharide PSK increases resistance of adult animals to challenge with syngeneic tumor cells and reduces azoxymethane-induced precancerous lesions in the colon.
ラット PVG/Seac(strainID=113) , DON/Kyo(strainID=1) , LEA/Hok(strainID=70) , DRH/Seac(strainID=111) , WF/Kop(strainID=510) , SDJ/Hok(strainID=74) , LE/Stm(strainID=265) , NIG-III/Hok(strainID=73) AKT is critically involved in cooperation between obesity and the dietary carcinogen amino-1-methyl-6-phenylimidazo [4,5-b] (PhIP) toward colon carcinogenesis in rats.
ラット F344-Apcm1Kyo(strainID=714) Use of a chemically induced-colon carcinogenesis-prone Apc-mutant rat in a chemotherapeutic bioassay.
一般微生物 JCM 5869 Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction.